(Q33748885)

29 July 2017

title

Bioanalysis of new designer drugs (English)

1 reference

29 July 2017

Ariane Wohlfarth

1

1 reference

29 July 2017

Wolfgang Weinmann

series ordinal

2

1 reference

29 July 2017

publication date

1 May 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

2

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

965-979

1 reference

Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts

29 July 2017

cites work

1 reference

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

Recent paramethoxyamphetamine deaths

21 January 2018

1 reference

Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA).

21 January 2018

1 reference

Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood

21 January 2018

1 reference

Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection.

21 January 2018

1 reference

Simultaneous determination of new thioamphetamine designer drugs in plasma by capillary electrophoresis coupled with mass spectrometry

21 January 2018

1 reference

Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry

21 January 2018

1 reference

Methylone and mCPP, two new drugs of abuse?

21 January 2018

1 reference

Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine

21 January 2018

1 reference

Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs)

21 January 2018

1 reference

CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)

21 January 2018

1 reference

Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)

21 January 2018

1 reference

The analytical profile of some 4-methylthioamphetamine (4-MTA) homologues

21 January 2018

1 reference

Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY.

21 January 2018

1 reference

Foxy, a designer tryptamine hallucinogen

21 January 2018

1 reference

A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy

21 January 2018

1 reference

21 January 2018

1 reference

Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market

21 January 2018

1 reference

New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.

21 January 2018

1 reference

Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone

21 January 2018

1 reference

Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine

21 January 2018

1 reference

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

21 January 2018

1 reference

New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

21 January 2018

1 reference

Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM])

21 January 2018

1 reference

Analysis of street drugs in seized material without primary reference standards

21 January 2018

1 reference

Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry

21 January 2018

1 reference

In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening

21 January 2018

1 reference

Determination of basic drugs of abuse in human serum by online extraction and LC-MS/MS.

21 January 2018

1 reference

Fatality due to acute alpha-methyltryptamine intoxication

21 January 2018

1 reference

Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.

21 January 2018

1 reference

Retrospective analysis of some L-methamphetamine/L-amphetamine urine data

21 January 2018

1 reference

Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS.

21 January 2018

1 reference

Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

21 January 2018

1 reference

Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.

21 January 2018

1 reference

A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.

21 January 2018

1 reference

Determination of amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection

21 January 2018

1 reference

Simultaneous determination of ten amphetamine designer drugs in human whole blood by capillary electrophoresis with diode array detection

21 January 2018

1 reference

LC-MS analysis of trimethoxyamphetamine designer drugs (TMA series) from urine samples

21 January 2018

1 reference

A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs

21 January 2018

1 reference

Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers

21 January 2018

1 reference

Multi-residue analysis of eight thioamphetamine designer drugs in human urine by liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.

21 January 2018

1 reference

New designer drug, 2,5-dimethoxy-4-propylthio-beta-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.

21 January 2018

1 reference

Postmortem Identification and Quantitation of 2,5-Dimethoxy-4-n-propylthiophenethylamine Using GC-MSD and GC-NPD

21 January 2018

1 reference

Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Analysis of designer drugs detected in the products purchased in fiscal year 2006

21 January 2018

1 reference

Fluoromethcathinone, a new substance of abuse

21 January 2018

1 reference

Combined intoxication with methylone and 5-MeO-MIPT.

21 January 2018

1 reference

Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

21 January 2018

1 reference

Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose

21 January 2018

1 reference

Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.

21 January 2018

1 reference

New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry

21 January 2018

1 reference

Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS).

21 January 2018

1 reference

New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

21 January 2018

1 reference

Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry

21 January 2018

1 reference

Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (

21 January 2018

1 reference

A2 (N-benzylpiperazine) a new drug of abuse in Sweden

21 January 2018

1 reference

Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.

21 January 2018

1 reference

Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?

21 January 2018

1 reference

Acute chlorophenylpiperazine overdose: a case report and review of the literature.

21 January 2018

1 reference

New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.

21 January 2018

1 reference

Isolation, identification and excretion profile of the principal urinary metabolite of the recently banned designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) in rats

21 January 2018

1 reference

Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenone

21 January 2018

1 reference

New designer drug 4′-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography–mass spectrometry

21 January 2018

1 reference

Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes.

21 January 2018

1 reference

Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry

21 January 2018

1 reference

Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure

21 January 2018

1 reference

A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation

21 January 2018

1 reference

Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites

21 January 2018

1 reference

A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation

21 January 2018

1 reference

'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

21 January 2018

1 reference

Spice: a never ending story?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/BIO.10.32

1 reference

29 July 2017

1 reference